TIETOJA TÄSTÄ JAKSOSTA
Are you making the most of immune checkpoint inhibitors in advanced gynecologic cancers?
Credit available for this activity expires: 10/5/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/precision-practice-optimizing-immunotherapy-recurrent-2026a1000zys?ecd=bdc_podcast_libsyn_mscpedu
Englanti
Yhdysvallat
TRANSKRIPTIO 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
HAE EDELLISIÄ EPISODEJA
Hae kanavan Keeping Current CME vanhoja jaksoja.
MUITA jaksoja TÄSSÄ PODCASTISSA
Experts discuss the latest efficacy and safety data on systemic treatments for prurigo nodularis.
Credit available for this activity expires: 10/12/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/itch-insight-prurigo-nodularis-countdown-2026a10010t5…
Where do oral obesity medications fit alongside injectables, and how can you match the right option to the right patient?
Credit available for this activity expires: 10/09/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-injectables-where-do-ora…
Experts discuss new clinical trial data and long-term safety of Janus kinase (JAK) inhibitors in alopecia areata (AA).
Credit available for this activity expires: 10/21/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pathway-prescription-alopecia-areata…
Experts discuss recent clinical guidelines and trial data on JAK inhibitors for systemic lupus erythematosus (SLE) treatment.
Credit available for this activity expires: 10/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/next-frontier-sle-management…
Vastuuvapautusilmoitus: Tälle sivulle upotettu podcast ja kuvitus ovat peräisin Medscape:ltä, joka on sen omistajan omaisuutta, eikä se ole sidoksissa Listen Notes, Inc:n tukemaan.
MUOKKAA
Kiitos, kun autoit pitämään podcast-tietokantaa ajan tasalla.
